

Samir Panvelker, MD
49 posts

@spanvelker
Endocrinologist interested in Onco-Endocrinology. Alum of @MedicineUVa, @UVaDOM, and @PennMedicine.






In the placebo-controlled LIXIPARK phase 2 trial involving persons with Parkinson’s disease, the subcutaneous GLP-1 receptor agonist lixisenatide was associated with reduced motor disability over a period of 12 months. Read the full trial results: nej.md/3J68HF8










I understand it's not the most realistic show in the world but the CPR scene in @obxnetflix is so unfortunate. It's easy for the public to misunderstand the basics when they see such poor compressions on TV. 2" deep while humming "Stayin' Alive," everyone!























Congratulations to Jennifer Kirby, MD PhD (Division of Endocrinology and Metabolism), who will receive the UVA Dean’s Award for Clinical Excellence at a ceremony in the spring. @gu_girl @UVA_Endocrine #UVAMedicine